Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaBritish Journal of Haematology
Volume 129, Issue 5, June 2005, Pages: 631–643, Nicolaus Kröger, Bronwen Shaw, Simona Iacobelli, Tatjana Zabelina, Karl Peggs, Avichai Shimoni, Arnon Nagler, Thomas Binder, Thomas Eiermann, Alejandro Madrigal, Rainer Schwerdtfeger, Michael Kiehl, Herbert Gottfried Sayer, Jörg Beyer, Martin Bornhäuser, Francis Ayuk, Axel Rolf Zander and David I. Marks, the Clinical Trial Committee of the British Society of Blood and Marrow Transplantation and the German Cooperative Transplant Group
Article first published online : 23 MAY 2005, DOI: 10.1111/j.1365-2141.2005.05513.x